Graft‐Versus‐Host Disease After Liver Transplantation
Ashley Wood, Bijan Eghtesad, Christina C. Lindenmeyer – 26 March 2020
High Protein Intake Is Associated With Histological Disease Activity in Patients With NAFLD
Sonja Lang, Anna Martin, Fedja Farowski, Hilmar Wisplinghoff, Maria J.G.T. Vehreschild, Jinyuan Liu, Marcin Krawczyk, Angela Nowag, Anne Kretzschmar, Jens Herweg, Bernd Schnabl, Xin M. Tu, Frank Lammert, Tobias Goeser, Frank Tacke, Kathrin Heinzer, Philipp Kasper, Hans‐Michael Steffen, Münevver Demir – 26 March 2020 – Overconsumption of carbohydrates and lipids are well known to cause nonalcoholic fatty liver disease (NAFLD), while the role of nutritional protein intake is less clear.
Treating Alcohol Use Disorder in Chronic Liver Disease
Eric R. Yoo, George Cholankeril, Aijaz Ahmed – 26 March 2020
Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma
Syed Irfan‐Ur Rahman, Laura Nunez‐Herrero, Jamie Lee Berkes – 26 March 2020
Development of Hepatocellular Carcinoma in Patients With Suppressed Viral Replication: Changes in Risk Over Time
Prowpanga Udompap, W. Ray Kim – 26 March 2020
Position 1: Transarterial Chemoembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocelluar Carcinoma
Wasseem Skef, Mitali Agarwal, Adam E. Mikolajczyk – 26 March 2020
Parenteral Nutrition–Associated Liver Disease
Kristen Nowak – 26 March 2020
Reply
Damiano Patrono, Eloisa Franchi, Francesco Lupo, Renato Romagnoli – 26 March 2020
Spotlight on Impactful Research: Utilization of Aspirin and Statin in Management of Coronary Artery Disease in Patients With Cirrhosis Undergoing Liver Transplant Evaluation
Leana Frankul, Catherine T. Frenette – 26 March 2020
Checkpoint Inhibitors for the Treatment of Advanced Hepatocellular Carcinoma
Laura A. Huppert, John D. Gordan, Robin Kate Kelley – 26 March 2020